AlphAIAlphAI — Financial news for AI agents
investing.comNOV 22 min read$THC

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

Original reporting
investing.com
Published Nov 2, 2026, 11:48 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 11:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$THC
Bullish
high confidence
Mentioned
$THC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$THCBullishHigh
01

Why it matters

The earnings surprise and analyst target increase provide a fresh catalyst for the stock.

02

Market read

Analyst upgrade and earnings beat create a short-term bullish bias for THC.

03

What to watch

Potential regulatory risk from ACA changes and Medicaid work requirements could pressure margins later.

Relevance 8/10Novelty 8/10Timing: today

Background

Tenet Healthcare reported Q3 2026 adjusted EPS of $6.64 versus $4.67 estimate and raised full-year EBITDA outlook.

Company-level read

Ticker impact

$THCBullishHigh confidence
Context

Mizuho raised Tenet Healthcare's price target to $305 and highlighted its earnings beat, providing fresh analyst guidance.

Expected impact

likely upward pressure as investors price in the higher target and earnings beat

Evidence & confidence

The new target is above current price and follows a strong earnings surprise, which typically drives buying.

Market effects

Sector

Positive earnings and target raise may lift other healthcare providers and hospital operators.

Regional

U.S. healthcare sector could see modest gains in early trading.

Global

Limited to U.S. markets; no direct global impact.

Counterpoint

What could challenge this read

The target raise may already be priced in; any miss on future guidance could reverse the rally.

Key entities

  • company
    Tenet Healthcare

    U.S. hospital operator (NYSE:THC).

  • analyst
    Mizuho

    Equity research firm raising price target.

Read at source← All news

Related articles

OCT 31
$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.

finance.yahoo.com6 min
OCT 30
$THCMed

High-acuity strategy helped Tenet weather surgery, uninsured headwinds in Q3

Tenet Healthcare raised its 2026 earnings guidance after its focus on high-acuity surgeries helped offset Q3 declines in procedure volumes. CEO Saum Sutaria cited the strategy's role in mitigating financial headwinds, including rising uninsured rates. Tenet expects full-year net income of $2.97B-$3.08B on revenues of $22.1B-$22.5B. Analysts noted Tenet's results were solid despite a challenging hospital sector.

finance.yahoo.com6 min
OCT 30
$THCMedAI 8/10

Guggenheim lowers Tenet Healthcare stock price target on 2027 outlook

Guggenheim reduced its price target for Tenet Healthcare (NYSE:THC) to $306 from $307, maintaining a Buy rating. The firm cited a modestly revised 2027 EBITDA outlook. Tenet's Q3 2026 earnings beat estimates, with adjusted EPS of $6.64 vs. $4.67 and revenue of $5.63B vs. $5.49B. The stock trades at $270.57, with a P/E ratio of 10.36 and a free cash flow yield of 15%.

investing.com2 min
OCT 29
$THCMedAI 8/10

Tenet Healthcare Corp (THC) Q3 2026 Earnings Call Highlights: Strong EPS Growth

Tenet Healthcare Corp (THC) reported Q3 2026 adjusted diluted EPS of $6.64, up 80%, driven by strong core business growth. USPI adjusted EBITDA rose 9% to $537 million, while hospital segment admissions grew 3.2%. Full-year 2026 adjusted EBITDA guidance was raised by $195 million. Challenges include exchange admissions decline and Conifer transition impacts. Management remains optimistic about 2027 earnings growth.

finance.yahoo.com6 min
OCT 29
$THCHighAI 9/10

Tenet (THC) Q3 2026 Earnings Call Transcript

Tenet Healthcare (THC) reported Q3 2026 revenue of $5.631B (+6.5% YoY) and adjusted EPS of $6.64 (+79.5% YoY). Adjusted EBITDA was $1.355B, with growth in ambulatory and hospital segments. The company raised FY2026 EBITDA guidance to $5.05B-$5.20B. Risks include an 18% decline in exchange admissions and Medicaid work requirements. Tenet issued $2B in senior unsecured notes and repurchased $1.615B in shares YTD.

fool.com3 min